APO Research
Talk to an analyst

APO RESEARCH · REPORT

Trifluridine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Trifluridine Market Outlook and Growth Opportunities 2026

1 February 2026190 pages

Choose your research edition.

Industry ResearchTrifluridine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Trifluridine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Trifluridine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Trifluridine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Trifluridine Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Trifluridine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Trifluridine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Trifluridine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Trifluridine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Trifluridine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Trifluridine market include Biophore, Lusochimica, Natco Pharma, Taiho Pharmaceutical, Yuki Gosei Kogyo and Shanghai Haoyuan Chemexpress, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Trifluridine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Trifluridine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Trifluridine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Trifluridine market size, projected growth trends, production technologies, key applications, and end-use industries.

Trifluridine Segment by Company

Biophore

Lusochimica

Natco Pharma

Taiho Pharmaceutical

Yuki Gosei Kogyo

Shanghai Haoyuan Chemexpress

Trifluridine Segment by Type

≥99%

<99%

Trifluridine Segment by Application

15 mg Tablet

20 mg Tablet

Trifluridine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Trifluridine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Trifluridine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Trifluridine significant trends, drivers, influence factors in global and regions.

6. To analyze Trifluridine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Trifluridine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Trifluridine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Trifluridine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Trifluridine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Trifluridine industry.

Chapter 3: Detailed analysis of Trifluridine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Trifluridine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Trifluridine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Trifluridine Industry Trends Table 2. Trifluridine Industry Drivers Table 3. Trifluridine Industry Opportunities and Challenges Table 4. Trifluridine Industry Restraints Table 5. Global Trifluridine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Trifluridine Revenue Share by Company (2021-2026) Table 7. Global Trifluridine Sales Volume by Company (t) & (2021-2026) Table 8. Global Trifluridine Sales Volume Share by Company (2021-2026) Table 9. Global Trifluridine Average Price (USD/t) of Company (2021-2026) Table 10. Global Trifluridine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Trifluridine Key Company Manufacturing Base & Headquarters Table 12. Global Trifluridine Company, Product Type & Application Table 13. Global Trifluridine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Trifluridine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of ≥99% Table 18. Significant Companies of <99% Table 19. Global Trifluridine Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Trifluridine Sales Volume by Type (2021-2026) & (t) Table 21. Global Trifluridine Sales Volume by Type (2027-2032) & (t) Table 22. Global Trifluridine Sales Volume Share by Type (2021-2026) Table 23. Global Trifluridine Sales Volume Share by Type (2027-2032) Table 24. Global Trifluridine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Trifluridine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Trifluridine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Trifluridine Sales Value Share by Type (2021-2026) Table 28. Global Trifluridine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of 15 mg Tablet Table 30. Significant Companies of 20 mg Tablet Table 31. Global Trifluridine Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 32. Global Trifluridine Sales Volume by Application (2021-2026) & (t) Table 33. Global Trifluridine Sales Volume by Application (2027-2032) & (t) Table 34. Global Trifluridine Sales Volume Share by Application (2021-2026) Table 35. Global Trifluridine Sales Volume Share by Application (2027-2032) Table 36. Global Trifluridine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Trifluridine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Trifluridine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Trifluridine Sales Value Share by Application (2021-2026) Table 40. Global Trifluridine Sales Value Share by Application (2027-2032) Table 41. Global Trifluridine Sales by Region: 2021 VS 2025 VS 2032 (t) Table 42. Global Trifluridine Sales by Region (2021-2026) & (t) Table 43. Global Trifluridine Sales Market Share by Region (2021-2026) Table 44. Global Trifluridine Sales by Region (2027-2032) & (t) Table 45. Global Trifluridine Sales Market Share by Region (2027-2032) Table 46. Global Trifluridine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Trifluridine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Trifluridine Sales Value Share by Region (2021-2026) Table 49. Global Trifluridine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Trifluridine Sales Value Share by Region (2027-2032) Table 51. Global Trifluridine Market Average Price (USD/t) by Region (2021-2026) Table 52. Global Trifluridine Market Average Price (USD/t) by Region (2027-2032) Table 53. Global Trifluridine Sales by Country: 2021 VS 2025 VS 2032 (t) Table 54. Global Trifluridine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Trifluridine Sales by Country (2021-2026) & (t) Table 56. Global Trifluridine Sales Market Share by Country (2021-2026) Table 57. Global Trifluridine Sales by Country (2027-2032) & (t) Table 58. Global Trifluridine Sales Market Share by Country (2027-2032) Table 59. Global Trifluridine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Trifluridine Sales Value Market Share by Country (2021-2026) Table 61. Global Trifluridine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Trifluridine Sales Value Market Share by Country (2027-2032) Table 63. Biophore Company Information Table 64. Biophore Business Overview Table 65. Biophore Trifluridine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 66. Biophore Trifluridine Product Portfolio Table 67. Biophore Recent Development Table 68. Lusochimica Company Information Table 69. Lusochimica Business Overview Table 70. Lusochimica Trifluridine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 71. Lusochimica Trifluridine Product Portfolio Table 72. Lusochimica Recent Development Table 73. Natco Pharma Company Information Table 74. Natco Pharma Business Overview Table 75. Natco Pharma Trifluridine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 76. Natco Pharma Trifluridine Product Portfolio Table 77. Natco Pharma Recent Development Table 78. Taiho Pharmaceutical Company Information Table 79. Taiho Pharmaceutical Business Overview Table 80. Taiho Pharmaceutical Trifluridine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 81. Taiho Pharmaceutical Trifluridine Product Portfolio Table 82. Taiho Pharmaceutical Recent Development Table 83. Yuki Gosei Kogyo Company Information Table 84. Yuki Gosei Kogyo Business Overview Table 85. Yuki Gosei Kogyo Trifluridine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 86. Yuki Gosei Kogyo Trifluridine Product Portfolio Table 87. Yuki Gosei Kogyo Recent Development Table 88. Shanghai Haoyuan Chemexpress Company Information Table 89. Shanghai Haoyuan Chemexpress Business Overview Table 90. Shanghai Haoyuan Chemexpress Trifluridine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. Shanghai Haoyuan Chemexpress Trifluridine Product Portfolio Table 92. Shanghai Haoyuan Chemexpress Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Trifluridine Distributors List Table 96. Trifluridine Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Trifluridine Product Image Figure 2. Global Trifluridine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Trifluridine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Trifluridine Sales (2021-2032) & (t) Figure 5. Global Trifluridine Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Trifluridine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. ≥99% Image Figure 10. <99% Image Figure 11. Global Trifluridine Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Trifluridine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Trifluridine Sales Volume Share by Type (2021-2032) Figure 14. Global Trifluridine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Trifluridine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Trifluridine Sales Value Share by Type (2021-2032) Figure 17. 15 mg Tablet Image Figure 18. 20 mg Tablet Image Figure 19. Global Trifluridine Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 20. Global Trifluridine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Trifluridine Sales Volume Share by Application (2021-2032) Figure 22. Global Trifluridine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Trifluridine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Trifluridine Sales Value Share by Application (2021-2032) Figure 25. Global Trifluridine Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 26. Global Trifluridine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Trifluridine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Trifluridine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Trifluridine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Trifluridine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Trifluridine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Trifluridine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Trifluridine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Trifluridine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Trifluridine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Trifluridine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Trifluridine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Trifluridine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Trifluridine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Trifluridine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Trifluridine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Trifluridine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Trifluridine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • ≥99%
  • <99%
Applications
  • 15 mg Tablet
  • 20 mg Tablet
Companies covered
  • Biophore
  • Lusochimica
  • Natco Pharma
  • Taiho Pharmaceutical
  • Yuki Gosei Kogyo
  • Shanghai Haoyuan Chemexpress

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Trifluridine Sales Value (2021-2032)
  4. 1.2.2 Global Trifluridine Sales Volume (2021-2032)
  5. 1.2.3 Global Trifluridine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Trifluridine Market Dynamics
  1. 2.1 Trifluridine Industry Trends
  2. 2.2 Trifluridine Industry Drivers
  3. 2.3 Trifluridine Industry Opportunities and Challenges
  4. 2.4 Trifluridine Industry Restraints
3 Trifluridine Market by Company
  1. 3.1 Global Trifluridine Company Revenue Ranking in 2025
  2. 3.2 Global Trifluridine Revenue by Company (2021-2026)
  3. 3.3 Global Trifluridine Sales Volume by Company (2021-2026)
  4. 3.4 Global Trifluridine Average Price by Company (2021-2026)
  5. 3.5 Global Trifluridine Company Ranking (2024-2026)
  6. 3.6 Global Trifluridine Company Manufacturing Base and Headquarters
  7. 3.7 Global Trifluridine Company Product Type and Application
  8. 3.8 Global Trifluridine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Trifluridine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Trifluridine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Trifluridine Market by Type
  1. 4.1 Trifluridine Type Introduction
  2. 4.1.1 ≥99%
  3. 4.1.2 <99%
  4. 4.2 Global Trifluridine Sales Volume by Type
  5. 4.2.1 Global Trifluridine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Trifluridine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Trifluridine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Trifluridine Sales Value by Type
  9. 4.3.1 Global Trifluridine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Trifluridine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Trifluridine Sales Value Share by Type (2021-2032)
5 Trifluridine Market by Application
  1. 5.1 Trifluridine Application Introduction
  2. 5.1.1 15 mg Tablet
  3. 5.1.2 20 mg Tablet
  4. 5.2 Global Trifluridine Sales Volume by Application
  5. 5.2.1 Global Trifluridine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Trifluridine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Trifluridine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Trifluridine Sales Value by Application
  9. 5.3.1 Global Trifluridine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Trifluridine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Trifluridine Sales Value Share by Application (2021-2032)
6 Trifluridine Regional Sales and Value Analysis
  1. 6.1 Global Trifluridine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Trifluridine Sales by Region (2021-2032)
  3. 6.2.1 Global Trifluridine Sales by Region: 2021-2026
  4. 6.2.2 Global Trifluridine Sales by Region (2027-2032)
  5. 6.3 Global Trifluridine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Trifluridine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Trifluridine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Trifluridine Sales Value by Region (2027-2032)
  9. 6.5 Global Trifluridine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Trifluridine Sales Value (2021-2032)
  12. 6.6.2 North America Trifluridine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Trifluridine Sales Value (2021-2032)
  15. 6.7.2 Europe Trifluridine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Trifluridine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Trifluridine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Trifluridine Sales Value (2021-2032)
  21. 6.9.2 South America Trifluridine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Trifluridine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Trifluridine Sales Value Share by Country, 2025 VS 2032
7 Trifluridine Country-level Sales and Value Analysis
  1. 7.1 Global Trifluridine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Trifluridine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Trifluridine Sales by Country (2021-2032)
  4. 7.3.1 Global Trifluridine Sales by Country (2021-2026)
  5. 7.3.2 Global Trifluridine Sales by Country (2027-2032)
  6. 7.4 Global Trifluridine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Trifluridine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Trifluridine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Trifluridine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Trifluridine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Trifluridine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Trifluridine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Trifluridine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Trifluridine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Trifluridine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Trifluridine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Trifluridine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Trifluridine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Trifluridine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Trifluridine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Trifluridine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Trifluridine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Trifluridine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Trifluridine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Trifluridine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Trifluridine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Trifluridine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Trifluridine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Trifluridine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Trifluridine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Trifluridine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Trifluridine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Trifluridine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Trifluridine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Trifluridine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Trifluridine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Trifluridine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Trifluridine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Trifluridine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Trifluridine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Trifluridine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Trifluridine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Trifluridine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Trifluridine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Trifluridine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Trifluridine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Trifluridine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Trifluridine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Trifluridine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Trifluridine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Trifluridine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Trifluridine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Trifluridine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Trifluridine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Trifluridine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Trifluridine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Trifluridine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Trifluridine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Trifluridine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Trifluridine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Trifluridine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Trifluridine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Trifluridine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Trifluridine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Trifluridine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Trifluridine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Trifluridine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Trifluridine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Trifluridine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Trifluridine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Trifluridine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Trifluridine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Trifluridine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Trifluridine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Trifluridine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Trifluridine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Trifluridine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Trifluridine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Trifluridine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Trifluridine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Trifluridine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Trifluridine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Trifluridine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Trifluridine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Trifluridine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Trifluridine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Trifluridine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Trifluridine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Trifluridine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Trifluridine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Trifluridine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Trifluridine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biophore
  2. 8.1.1 Biophore Company Information
  3. 8.1.2 Biophore Business Overview
  4. 8.1.3 Biophore Trifluridine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Biophore Trifluridine Product Portfolio
  6. 8.1.5 Biophore Recent Developments
  7. 8.2 Lusochimica
  8. 8.2.1 Lusochimica Company Information
  9. 8.2.2 Lusochimica Business Overview
  10. 8.2.3 Lusochimica Trifluridine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lusochimica Trifluridine Product Portfolio
  12. 8.2.5 Lusochimica Recent Developments
  13. 8.3 Natco Pharma
  14. 8.3.1 Natco Pharma Company Information
  15. 8.3.2 Natco Pharma Business Overview
  16. 8.3.3 Natco Pharma Trifluridine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Natco Pharma Trifluridine Product Portfolio
  18. 8.3.5 Natco Pharma Recent Developments
  19. 8.4 Taiho Pharmaceutical
  20. 8.4.1 Taiho Pharmaceutical Company Information
  21. 8.4.2 Taiho Pharmaceutical Business Overview
  22. 8.4.3 Taiho Pharmaceutical Trifluridine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Taiho Pharmaceutical Trifluridine Product Portfolio
  24. 8.4.5 Taiho Pharmaceutical Recent Developments
  25. 8.5 Yuki Gosei Kogyo
  26. 8.5.1 Yuki Gosei Kogyo Company Information
  27. 8.5.2 Yuki Gosei Kogyo Business Overview
  28. 8.5.3 Yuki Gosei Kogyo Trifluridine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Yuki Gosei Kogyo Trifluridine Product Portfolio
  30. 8.5.5 Yuki Gosei Kogyo Recent Developments
  31. 8.6 Shanghai Haoyuan Chemexpress
  32. 8.6.1 Shanghai Haoyuan Chemexpress Company Information
  33. 8.6.2 Shanghai Haoyuan Chemexpress Business Overview
  34. 8.6.3 Shanghai Haoyuan Chemexpress Trifluridine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Haoyuan Chemexpress Trifluridine Product Portfolio
  36. 8.6.5 Shanghai Haoyuan Chemexpress Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Trifluridine Value Chain Analysis
  2. 9.1.1 Trifluridine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Trifluridine Sales Mode & Process
  6. 9.2 Trifluridine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Trifluridine Distributors
  9. 9.2.3 Trifluridine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst